A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Daclizumab (Primary) ; Mycophenolate mofetil (Primary) ; Ciclosporin; Corticosteroids; Corticosteroids
- Indications Renal transplant rejection
- Focus Registrational; Therapeutic Use
- Acronyms CAESAR
- Sponsors Roche
- 01 Dec 2008 Actual end date March 2004, reported by ClinicalTrials.gov.
- 08 Aug 2006 Status change
- 24 Nov 2005 New trial record.